Toxoplasmosis pathogens cannot be completely eradicated from infected hosts.
Toxoplasma gondii forms persistent tissue cysts and latent stages inside infected hosts that cannot be completely eradicated by current medical treatments or immune responses.
Multiple papers confirm that Toxoplasma gondii establishes a chronic, latent phase characterized by tissue cysts containing bradyzoites. These encysted forms evade immune clearance and current pharmacological treatments, meaning the pathogen cannot be completely eradicated from infected hosts.
Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.. 2018. https://doi.org/10.1128/cmr.00057-17
Current clinical regimens are unable to eliminate the latent stage of Toxoplasma gondii infection.
See more details
Cerutti A, Blanchard N, Besteiro S. The Bradyzoite: A Key Developmental Stage for the Persistence and Pathogenesis of Toxoplasmosis.. 2020. https://doi.org/10.3390/pathogens9030234
The parasite persists as dormant bradyzoites that are not eliminated by existing medical treatments.
Akins GKH, Furtado JM, Smith JR. Diseases Caused by and Behaviors Associated with <i>Toxoplasma gondii</i> Infection.. 2024. https://doi.org/10.3390/pathogens13110968
No current treatment regimens are curative for chronic Toxoplasma gondii infection.
Matthew D. White, R. Angara, Leticia Torres Dias, Dhananjay D. Shinde, V. Thomas, Leonardo Augusto. Selective host autophagy is induced during the intracellular parasite Toxoplasma gondii infection controlling amino acid levels. 2024. https://doi.org/10.1128/msphere.00369-24
Existing treatments and immune responses fail to entirely eliminate the chronic persisting forms of the parasite.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt